Intelligent Bio Solutions clears cybersecurity, software review items ahead of FDA 510(k) filing in H2 2026 - INBS News | RalliesIntelligent Bio Solutions clears cybersecurity, software review items ahead of FDA 510(k) filing in H2 2026
I
INBS• Cybersecurity and software review items cleared
- Intelligent Bio Solutions cleared cybersecurity and software documentation items tied to its planned FDA 510(k) filing.
- Submission remains slated for H2 2026, targeting initial clearance for codeine detection.
- Penetration-test remediation reached 100% for medium-risk issues; low-risk items cut to 2 from 11.
XLE
•
